2022-RA-1387-ESGO Patients with minimal residual disease at upfront debulking surgery have similar s...
2022-RA-1387-ESGO Patients with minimal residual disease at upfront debulking surgery have similar survival outcome than patients with complete cytorreduction after neoadjuvant chemotherapy
About this item
Full title
Author / Creator
Romero, Violeta , Angeles, Martina Aida , Gonzalez, Elena Rodriguez , Navarro, Anne Sophie , Spagnolo, Emmanuela , Pérez-Benavente, Asunción , Cabarrou, Bastien , Bataillon, Guillaume , Migliorelli, Federico , Rychlik, Agnieszka , Guyon, Frédéric , Bétrian, Sarah , Gil-Moreno, Antonio , Ferron, Gwénaël , Hernández, Alicia and Martínez, Alejandra
Publisher
Kidlington: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
Introduction/BackgroundComplete primary debulking surgery (PDS) is the mainstay of treatment for advanced ovarian cancer. However, three randomized trials have demonstrated non-inferiority survival outcome of neoadjuvant chemotherapy followed by interval debulking surgery (IDS). It is widely accepted that NACT is the preferred approach for patients...
Alternative Titles
Full title
2022-RA-1387-ESGO Patients with minimal residual disease at upfront debulking surgery have similar survival outcome than patients with complete cytorreduction after neoadjuvant chemotherapy
Authors, Artists and Contributors
Author / Creator
Angeles, Martina Aida
Gonzalez, Elena Rodriguez
Navarro, Anne Sophie
Spagnolo, Emmanuela
Pérez-Benavente, Asunción
Cabarrou, Bastien
Bataillon, Guillaume
Migliorelli, Federico
Rychlik, Agnieszka
Guyon, Frédéric
Bétrian, Sarah
Gil-Moreno, Antonio
Ferron, Gwénaël
Hernández, Alicia
Martínez, Alejandra
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2728883909
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2728883909
Other Identifiers
ISSN
1048-891X
E-ISSN
1525-1438
DOI
10.1136/ijgc-2022-ESGO.703
